Description: Prosit Sole Biotechnology
Prosite Sole is the proud inventor and owner of a patented Biologics discovery platform and a robust product pipeline, with 6 innovative therapeutics for a range of severe rare diseases. Each biologics molecule is designed to be de-risked as well as likely to be speedily approvable by FDA and CFDA. The company possesses full capability of protein design by the patented P-POP protein chimeric platform, drug screening, cell banking, high quality scale-up/manufacturing, animal disease models, preclinical and
PEG Interferon Lambda Chimera A new Antiviral Cytokine from the Type III Interferon Family With Significantly Improved Safety Profile Specifically No bone Marrow Toxicity
Prosit Sole Biotechnology Initiates First-In-Human Clinical Trial of Novel Interferon Lambda Chimera in US